The effect of bioactive catheters sustained-release growth factors (GFS) on peripheral nerve regeneration and functional recovery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036548

Enrollment

Unknown

Registered

2020-08-24

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral nerve injury

Interventions

experimental group:Bioactive catheters

control group:routine operation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Patients with facial nerve injury; (2) There was a history of facial nerve injury; (3) The age ranged from 20 to 65 years old; (4) After drug treatment, the symptoms were not significantly relieved; (5) The conduction velocity of facial nerve was decreased; (6) Ultrasound showed nerve injury. (7) The subjects signed informed consent.

Exclusion criteria

Exclusion criteria: (1) History of brainstem lesions; (2) There are related risk factors such as neuromuscular junction lesions; (3) Facial muscle diseases.

Design outcomes

Primary

Measure	Time frame
Nerve conduction velocity;	—

Countries

China

Contacts

Public ContactFukai Ma

The Ninth People's Hospital Affiliated to medical school of Shanghai Jiaotong University

569463047@qq.com+86 15618057168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026